Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies

Similar Items

• Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies
  by: Laura C. Coates, et al.
  Published: (2019-12-01)
• Effect of secukinumab on the different GRAPPA-OMERACT core domains in psoriatic arthritis: a pooled analysis of 2049 patients
  by: Orbai, A-M, et al.
  Published: (2019)
• Clinically relevant patient clusters identified by machine learning from the clinical development programme of secukinumab in psoriatic arthritis
  by: Pournara, E, et al.
  Published: (2021)
• Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data
  by: A. Deodhar, et al.
  Published: (2019-05-01)
• Effects of TNF-α inhibition secukinumab on active ultrasound-confirmed enthesitis in psoriatic arthritis
  by: Ashley Elliott, et al.
  Published: (2023-11-01)